摘要:
Metal complexes of the general formula I[R.sup.1 (CH.sub.2).sub.m C(O)CR.sup.3 C(O)R.sup.2 ].sub.2 M(OR.sup.4).sub.2-n X.sub.n (I)wherein M denotes titanium, zirconium or hafnium, R.sup.1 denotes hydrogen, C.sub.1 -C.sub.8 -alkyl or phenyl, which can be monosubstituted or polysubstituted by fluorine, chlorine, bromine, nitro, C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy or trifluoromethyl, R.sup.2 denotes C.sub.1 -C.sub.8 -alkyl, or phenyl, which can be monosubstituted or polysubstituted by fluorine, chlorine, bromine, nitro, C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy or trifluoromethyl, R.sup.3 denotes hydrogen or phenyl, R.sup.4 denotes C.sub.1 -C.sub.18 -alkyl, which can be substituted by hydroxyl, C.sub.1 -C.sub.3 -alkylamino or alkali metal sulfonato groups, or denotes C.sub.5 -C.sub.8 -cycloalkyl, which can be substituted by C.sub.1 -C.sub.5 -alkyl groups, hydroxyl or alkali metal sulfonato groups, X denotes fluorine, chlorine or bromine, m denotes the number 0 or 1, but does not denote 0 if R.sup.1 denotes hydrogen, and n denotes the number 0 or 1, and, if a radical R.sup.4 contains an amino group, hydrohalides thereof, exhibit a very good cytostatic activity, coupled with low toxicity. They are suitable for the production of medicaments having an antineoplastic action.
摘要:
Complexes of the general formula I[R.sup.1 (CH.sub.2).sub.m C(O)CR.sup.3 C(O)R.sup.2 ].sub.2+n MX.sub.2-n (I)wherein M denotes tin, titanium, zirconium or hafnium, R.sup.1 denotes hydrogen or a phenyl radical, it being possible for the phenyl radical to be monosubstituted or polysubstituted by fluorine, chlorine, bromine, nitro, C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy or trifluoromethyl, R.sup.2 denotes methyl or R.sup.1, with the exception of hydrogen, R.sup.3 denotes hydrogen or chlorine, X denotes fluorine, chlorine or bromine, but not fluorine if M denotes zirconium or hafnium, m denotes the number 1 or 0, or, if R.sup.1 denotes hydrogen, the number 1 and n denotes the number 0, or, if M denotes zirconium or hafnium, the number 1 or 0, exhibit a cytostatic activity which is comparable to that of cisplatin and are less toxic than cisplatin. They are suitable for the produduction of medicaments having an anti-neoplastic action.
摘要:
A compound of the general formula I(BH.sub.n).sub.m [RuX.sub.3+nm-q-r.sup.(OH).sub.r (BH.sub.p).sub.3-nm+q ].sub.1+p+q IwhereinB denotes a mononuclear or polynuclear basic heterocyclic radical containing one or more nitrogen atoms,X denotes chlorine or bromine,m denotes 1 or 2,n denotes 1 or 2, the sum of n and m being not greater than 3,p denotes 0 or 1, but not 1 if n is 1,q denotes 0 or 1, but not 1 if p is 1 andr denotes 0 or 1,show an antitumoral activity and are therefore suitable as a chemotherapeutic for the treatment of cancers.
摘要:
This invention relates to anellated azepinone derivatives, a method of their production, metal complexes of the anellated azepinone derivatives as well as their use in the treatment of tumor diseases.
摘要:
The invention relates to cerium compounds having general formulas (I) Rni+Yin− and (II) Rb+Yb+ and their application as medicaments in the prophylaxis and/or treatment of cancer diseases. In formula (I), R is a group of general formula (A): and in formula (II), Rb is a group of general formula (B)
摘要:
A method for treatment of viral infections or tumors, comprising administering a gallium complex of the formula: ##STR1## wherein R.sub.1 represents hydrogen, a halogen or a sulfono group SO.sub.3 M in which M is a metal ion such as potassium or sodium, and R.sub.2 represents hydrogen, or R.sub.1 is chlorine and R.sub.2 is iodo.
摘要:
Compositions, containing a ruthenium(III) complex and a heterocycle, methods for their manufacture, medicament containing these compositions and a kit.The invention relates to a composition (A), obtained by reacting a compound of the general formula (I) M3−n−p−2pr[RUX6−n−p−q−2rBn(H2O)p(OH)q(O)r]2r+1 (I) with a compound of the general formula (II) B′(HX′)s (II). Furthermore, the invention relates to a composition (B), obtained by mixing a compound of the general formula (III) (B′H)3−n−p−2pr[RUX6−n−p−q−2rBn(H2O)p(OH)q(O)r]2r+1 (III) with a compound of the general formula (IV) MX′ (IV).
摘要:
Compositions, containing a ruthenium(III) complex and a heterocycle, methods for their manufacture, medicament containing these compositions and a kit.The invention relates to a composition (A), obtained by reacting a compound of the general formula (I) M3−n−p−2pr[RuX6−n−p−q−2rBn(H2O)p(OH)q(O)r]2r+1 (I) with a compound of the general formula (II) B′(HX′)S. (II) Furthermore, the invention relates to a composition (B), obtained by mixing a compound of the general formula (III) (B′H)3−n−p−2pr[RuX6−n−p−q−2rBn(H2O)p(OH)q(O)r]2r+1 (III) with a compound of the general formula (IV) MX′. (IV)